Becton Dickinson & Co (NYSE:BDX) is classified as a component of the 164 company Health Care Equipment & Supplies GICS industry group, which is part of the 785 company GICS Health Care sector. The market value of BDX is $51.1 billion which falls in the top 10% of its industry group. The stock's current Portfolio Grader score places it 14 among the 164 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 34 among the 785 companies in the sector, and number 255 in the nearly 5,000 company Portfolio Grader universe.

Portfolio Grader currently ranks Becton Dickinson & Co (NYSE:BDX) a Buy. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool researches nearly 5,000 stocks weekly. The current Portfolio Grader recommendation on the shares has been in place for 5 months.

Becton Dickinson & Co (NYSE:BDX) is ranked as a Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BDX has had from Portfolio Grader for 5 months.

Portfolio Grader currently ranks Becton Dickinson & Co (NYSE:BDX) a Buy. The methodology for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. This represents no change from the previous week and is the same ranking BDX has had from Portfolio Grader for 5 months.

Portfolio Grader currently ranks Becton Dickinson & Co (NYSE:BDX) a Buy. The approach to investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current Portfolio Grader recommendation on the shares has been in place for 4 months.